A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins

FASEB Journal

Volumn 27, Issue 12, 2013, Pages 4965-4974

  Thomsen, Christer ^a   Grundevik, Pernilla ^a   Elias, Per ^a   Ståhlberg, Anders ^a   Åman, Pierre ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Neurodegenerative diseases; Neuropathology; Tumor biology

Indexed keywords

FUSED IN SARCOMA PROTEIN; ONCOPROTEIN; PROTEIN EWSR1; PROTEIN TAF15; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; DNA BINDING; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA BINDING;

NEURODEGENERATIVE DISEASES; NEUROPATHOLOGY; TUMOR BIOLOGY;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BINDING SITES; CALMODULIN-BINDING PROTEINS; CELL LINE, TUMOR; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA-BINDING PROTEIN FUS; RNA-BINDING PROTEINS; TATA-BINDING PROTEIN ASSOCIATED FACTORS;

EID: 84890521089     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-234435     Document Type: Article

References (55)

1. Crozat, A., Åman, P., Mandahl, N., and Ron, D. (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 640-644
2. Rabbitts, T. H., Forster, A., Larson, R., and Nathan, P. (1993) Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat. Genet. 4, 175-180
3. Åman, P., Ron, D., Mandahl, N., Fioretos, T., Heim, S., Arheden, K., Willen, H., Rydholm, A., and Mitelman, F. (1992) Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer 5, 278-285
4. Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., Aurias, A., and Thomas, G. (1992) Gene fusion with an ETS DNAbinding domain caused by chromosome translocation in human tumours. Nature 359, 162-165
5. Bertolotti, A., Lutz, Y., Heard, D. J., Chambon, P., and Tora, L. (1996) hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 15, 5022-5031
6. Kwiatkowski, T. J., Jr., Bosco, D. A., Leclerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T., Valdmanis, P., Rouleau, G. A., Hosler, B. A., Cortelli, P., de Jong, P. J., Yoshinaga, Y., Haines, J. L., Pericak-Vance, M. A., Yan, J., Ticozzi, N., Siddique, T., McKenna-Yasek, D., Sapp, P. C., Horvitz, H. R., Landers, J. E., and Brown, R. H., Jr. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208
7. Lagier-Tourenne, C., Polymenidou, M., and Cleveland, D. W. (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 19, R46-R64
8. Mitchell, J. C., McGoldrick, P., Vance, C., Hortobagyi, T., Sreedharan, J., Rogelj, B., Tudor, E. L., Smith, B. N., Klasen, C., Miller, C. C., Cooper, J. D., Greensmith, L., and Shaw, C. E. (2013) Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age-and dose-dependent fashion. Acta Neuropathol. 125, 273-288
9. Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., Ganesalingam, J., Williams, K. L., Tripathi, V., Al-Saraj, S., Al-Chalabi, A., Leigh, P. N., Blair, I. P., Nicholson, G., de Belleroche, J., Gallo, J. M., Miller, C. C., and Shaw, C. E. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211
10. Munoz, D. G., Neumann, M., Kusaka, H., Yokota, O., Ishihara, K., Terada, S., Kuroda, S., and Mackenzie, I. R. (2009) FUS pathology in basophilic inclusion body disease. Acta Neuropathol. 118, 617-627
11. Woulfe, J., Gray, D. A., and Mackenzie, I. R. (2010) FUSimmunoreactive intranuclear inclusions in neurodegenerative disease. Brain Pathol. 20, 589-597
12. Andersson, M. K., Ståhlberg, A., Arvidsson, Y., Olofsson, A., Semb, H., Stenman, G., Nilsson, O., and Åman, P. (2008) The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol. 9, 37
13. Fujii, R., and Takumi, T. (2005) TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J. Cell Sci. 118, 5755-5765
14. Bertolotti, A., Bell, B., and Tora, L. (1999) The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties. Oncogene 18, 8000-8010
15. Lee, J., Rhee, B. K., Bae, G. Y., Han, Y. M., and Kim, J. (2005) Stimulation of Oct-4 activity by Ewing's sarcoma protein. Stem Cells 23, 738-751
16. Tan, A. Y., Riley, T. R., Coady, T., Bussemaker, H. J., and Manley, J. L. (2012) TLS/FUS (translocated in liposarcoma/ fused in sarcoma) regulates target gene transcription via singlestranded DNA response elements. Proc. Natl. Acad. Sci. U. S. A. 109, 6030-6035
17. Thomas, G. R., and Latchman, D. S. (2002) The pro-oncoprotein EWS (Ewing's Sarcoma protein) interacts with the Brn-3a POU transcription factor and inhibits its ability to activate transcription. Cancer Biol. Ther. 1, 428-432
18. Law, W. J., Cann, K. L., and Hicks, G. G. (2006) TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief. Funct. Genomic. Proteomic. 5, 8-14
19. Paronetto, M. P., Minana, B., and Valcarcel, J. (2011) The Ewing sarcoma protein regulates DNA damage-induced alternative splicing. Mol Cell. 43, 353-368
20. Rappsilber, J., Ryder, U., Lamond, A. I., and Mann, M. (2002) Large-scale proteomic analysis of the human spliceosome. Genome Res. 12, 1231-1245
21. Yang, L., Embree, L. J., Tsai, S., and Hickstein, D. D. (1998) Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J. Biol. Chem. 273, 27761-27764
22. Zinszner, H., Sok, J., Immanuel, D., Yin, Y., and Ron, D. (1997) TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell Sci. 110 (Pt 15), 1741-1750
23. Morlando, M., Dini Modigliani, S., Torrelli, G., Rosa, A., Di Carlo, V., Caffarelli, E., and Bozzoni, I. (2012) FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 31, 4502-4510
24. Kuroda, M., Sok, J., Webb, L., Baechtold, H., Urano, F., Yin, Y., Chung, P., de Rooij, D. G., Akhmedov, A., Ashley, T., and Ron, D. (2000) Male sterility and enhanced radiation sensitivity in TLS(-/-) mice. EMBO J. 19, 453-462
25. Li, H., Watford, W., Li, C., Parmelee, A., Bryant, M. A., Deng, C., O'Shea, J., and Lee, S. B. (2007) Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development. J. Clin. Invest. 117, 1314-1323
26. Hicks, G. G., Singh, N., Nashabi, A., Mai, S., Bozek, G., Klewes, L., Arapovic, D., White, E. K., Koury, M. J., Oltz, E. M., Van Kaer, L., and Ruley, H. E. (2000) Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat. Genet. 24, 175-179
27. Hoell, J. I., Larsson, E., Runge, S., Nusbaum, J. D., Duggimpudi, S., Farazi, T. A., Hafner, M., Borkhardt, A., Sander, C., and Tuschl, T. (2011) RNA targets of wild-type and mutant FET family proteins. Nat. Struct. Mol. Biol. 18, 1428-1431
28. Blechingberg, J., Luo, Y., Bolund, L., Damgaard, C. K., and Nielsen, A. L. (2012) Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions. PloS One 7, e46251
29. Lagier-Tourenne, C., Polymenidou, M., Hutt, K. R., Vu, A. Q., Baughn, M., Huelga, S. C., Clutario, K. M., Ling, S. C., Liang, T. Y., Mazur, C., Wancewicz, E., Kim, A. S., Watt, A., Freier, S., Hicks, G. G., Donohue, J. P., Shiue, L., Bennett, C. F., Ravits, J., Cleveland, D. W., and Yeo, G. W. (2012) Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 15, 1488-1497
30. Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, A., Than, M. E., Mackenzie, I. R., Capell, A., Schmid, B., Neumann, M., and Haass, C. (2010) ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 29, 2841-2857
31. Riggi, N., Cironi, L., Suva, M. L., and Stamenkovic, I. (2007) Sarcomas: genetics, signalling, and cellular origins. Part 1: the fellowship of TET. J. Pathol. 213, 4-20
32. Lee, K. A. (2007) Ewings family oncoproteins: drunk, disorderly and in search of partners. Cell Res. 17, 286-288
33. Ng, K. P., Potikyan, G., Savene, R. O., Denny, C. T., Uversky, V. N., and Lee, K. A. (2007) Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins. Proc. Natl. Acad. Sci. U. S. A. 104, 479-484
34. Dyson, H. J., and Wright, P. E. (2005) Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6, 197-208
35. Thelin-Jarnum, S., Goransson, M., Burguete, A. S., Olofsson, A., and Åman, P. (2002) The myxoid liposarcoma specific TLSCHOP fusion protein localizes to nuclear structures distinct from PML nuclear bodies. Int. J. Cancer 97, 446-450
36. Goransson, M., Wedin, M., and Åman, P. (2002) Temperaturedependent localization of TLS-CHOP to splicing factor compartments. Exp. Cell Res. 278, 125-132
37. Goransson, M., Andersson, M. K., Forni, C., Ståhlberg, A., Andersson, C., Olofsson, A., Mantovani, R., and Åman, P. (2009) The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ. Oncogene 28, 270-278
38. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., Thompson, J. D., Gibson, T. J., and Higgins, D. G. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948
39. Papadopoulos, J. S., and Agarwala, R. (2007) COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics 23, 1073-1079
40. Dinkel, H., Michael, S., Weatheritt, R. J., Davey, N. E., Van Roey, K., Altenberg, B., Toedt, G., Uyar, B., Seiler, M., Budd, A., Jodicke, L., Dammert, M. A., Schroeter, C., Hammer, M., Schmidt, T., Jehl, P., McGuigan, C., Dymecka, M., Chica, C., Luck, K., Via, A., Chatr-Aryamontri, A., Haslam, N., Grebnev, G., Edwards, R. J., Steinmetz, M. O., Meiselbach, H., Diella, F., and Gibson, T. J. (2012) ELM-the database of eukaryotic linear motifs. Nucleic Acids Res. 40, D242-251
41. Tan, A. Y., and Manley, J. L. (2009) The TET family of proteins: functions and roles in disease. J. Mol. Cell. Biol. 1, 82-92
42. Gardiner, M., Toth, R., Vandermoere, F., Morrice, N. A., and Rouse, J. (2008) Identification and characterization of FUS/ TLS as a new target of ATM. Biochem. J. 415, 297-307
43. Klevernic, I. V., Morton, S., Davis, R. J., and Cohen, P. (2009) Phosphorylation of Ewing's sarcoma protein (EWS) and EWSFli1 in response to DNA damage. Biochem. J. 418, 625-634
44. Bento, C., Andersson, M. K., and Åman, P. (2009) DDIT3/ CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLSCHOP bind cyclin-dependent kinase 2. BMC Cell Biol. 10, 89
45. Spahn, L., Siligan, C., Bachmaier, R., Schmid, J. A., Aryee, D. N., and Kovar, H. (2003) Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein. Oncogene 22, 6819-6829
46. Embree, L. J., Azuma, M., and Hickstein, D. D. (2009) Ewing sarcoma fusion protein EWSR1/FLI1 interacts with EWSR1 leading to mitotic defects in zebrafish embryos and human cell lines. Cancer Res. 69, 4363-4371
47. Pahlich, S., Quero, L., Roschitzki, B., Leemann-Zakaryan, R. P., and Gehring, H. (2009) Analysis of Ewing sarcoma (EWS)-binding proteins: interaction with hnRNP M, U, and RNAhelicases p68/72 within protein-RNA complexes. J. Proteome Res. 8, 4455-4465
48. Kato, M., Han, T. W., Xie, S., Shi, K., Du, X., Wu, L. C., Mirzaei, H., Goldsmith, E. J., Longgood, J., Pei, J., Grishin, N. V., Frantz, D. E., Schneider, J. W., Chen, S., Li, L., Sawaya, M. R., Eisenberg, D., Tycko, R., and McKnight, S. L. (2012) Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 149, 753-767
49. Han, T. W., Kato, M., Xie, S., Wu, L. C., Mirzaei, H., Pei, J., Chen, M., Xie, Y., Allen, J., Xiao, G., and McKnight, S. L. (2012) Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell 149, 768-779
50. Araya, N., Hirota, K., Shimamoto, Y., Miyagishi, M., Yoshida, E., Ishida, J., Kaneko, S., Kaneko, M., Nakajima, T., and Fukamizu, A. (2003) Cooperative interaction of EWS with CREB-binding protein selectively activates hepatocyte nuclear factor 4-mediated transcription. J. Biol. Chem. 278, 5427-5432
51. Belyanskaya, L. L., Delattre, O., and Gehring, H. (2003) Expression and subcellular localization of Ewing sarcoma (EWS) protein is affected by the methylation process. Exp. Cell Res. 288, 374-381
52. Belyanskaya, L. L., Gehrig, P. M., and Gehring, H. (2001) Exposure on cell surface and extensive arginine methylation of ewing sarcoma (EWS) protein. J. Biol. Chem. 276, 18681-18687
53. Dormann, D., Madl, T., Valori, C. F., Bentmann, E., Tahirovic, S., Abou-Ajram, C., Kremmer, E., Ansorge, O., Mackenzie, I. R., Neumann, M., and Haass, C. (2012) Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J. 31, 4258-4275
54. Couthouis, J., Hart, M. P., Erion, R., King, O. D., Diaz, Z., Nakaya, T., Ibrahim, F., Kim, H. J., Mojsilovic-Petrovic, J., Panossian, S., Kim, C. E., Frackelton, E. C., Solski, J. A., Williams, K. L., Clay-Falcone, D., Elman, L., McCluskey, L., Greene, R., Hakonarson, H., Kalb, R. G., Lee, V. M., Trojanowski, J. Q., Nicholson, G. A., Blair, I. P., Bonini, N. M., Van Deerlin, V. M., Mourelatos, Z., Shorter, J., and Gitler, A. D. (2012) Evaluating the role of the FUS/TLSrelated gene EWSR1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 21, 2899-2911
55. Neumann, M., Bentmann, E., Dormann, D., Jawaid, A., DeJesus-Hernandez, M., Ansorge, O., Roeber, S., Kretzschmar, H. A., Munoz, D. G., Kusaka, H., Yokota, O., Ang, L. C., Bilbao, J., Rademakers, R., Haass, C., and Mackenzie, I. R. (2011) FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 134, 2595-2609